2 result(s) for
| PI Name | Protocol # | Title |
|---|---|---|
| Lara Davis | IRB00010529 | SARC024: A blanket protocol to study oral regorafenib in patients with selected sarcoma subtypes |
| Lara Davis | STUDY00022158 | SARC038: A Phase 2 Study of Regorafenib in Combination with Nivolumab in Patients with Refractory or Recurrent Osteosarcoma |
You may also qualify for Phase 1 Program trials.